Literature DB >> 23905112

Role of TSH on Urinary Calcium Excretion In Post Menopausal Women of South Indian Population.

Niranjan G1, Amrutha P V, Srinivasan A R, Ramesh R, Sathishbabu M, Sathiya R.   

Abstract

BACKGROUND: Unforeseen aberrations in the hormonal status during the early postmenopausal period are responsible for several complications including osteoporosis. Thyroid Stimulating Hormone (TSH) receptors are isolated from various tissues including the bone. A low serum TSH level is known to stimulate osteoclastic activity in bone and accelerate bone resorption. Urinary calcium/creatinine (UCa/Cr) excretion ratio could be an indirect and an early indicator of loss of Bone Mineral Density (BMD). With this background, this study was planned to explore the association of serum TSH levels with the UCa/Cr excretion ratio.
METHODS: Forty eight women in the postmenopausal age group, with their menopausal age not more than seven years of duration were included in this study. Based on their TSH values, these subjects were divided into two groups A (TSH<0.5 mIU/L) and B (TSH>0.5mIU/L). Urinary calcium, UCa/Cr excretion ratio, serum phosphorous, calcium and calcium phosphorous multiplication products were estimated and compared between the two groups.
RESULTS: Twenty two (46%) women were biochemically asymptomatic hyperthyroid cases and Twenty six (54%) were euthyroid. This study documents high UCa/Cr in Group A compared to that of Group B (p<0.05). We also observed significant negative correlation of TSH with UCa/Cr excretion ratio (p=0.041, r = -0.43).
CONCLUSION: Low serum TSH levels were associated with increased UCa/Cr excretion ratio in postmenopausal women of South Indian population.

Entities:  

Keywords:  Post Menopausal Women; Thyroid Stimulating Hormone; Urinary Calcium/creatinine ratio; Urinary calcium

Year:  2013        PMID: 23905112      PMCID: PMC3708207          DOI: 10.7860/JCDR/2013/5290.3056

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  20 in total

1.  [Calcium-phosphorus metabolism and bone metabolism in postmenopausal patients with the thyroid gland pathology].

Authors:  A E Esedova; M M Gadzhieva; R A Ferzilaeva
Journal:  Klin Lab Diagn       Date:  2002-03

2.  Bone loss in premenopausal women on long-term suppressive therapy with thyroid hormone.

Authors:  S Sijanovic; I Karner
Journal:  Medscape Womens Health       Date:  2001-10

3.  The relationship between thyroid function and bone mineral density in euthyroid healthy subjects in Taiwan.

Authors:  Jiunn-Diann Lin; Dee Pei; Te-Lin Hsia; Chung-Ze Wu; Kun Wang; Yen-Lin Chang; Chun-Hsin Hsu; Yen-Lin Chen; Kwang-Wen Chen; Sai-Hung Tang
Journal:  Endocr Res       Date:  2011       Impact factor: 1.720

4.  Relation to osteoporosis of age- and hormone-induced changes in the metabolism of collagen and bone.

Authors:  O Laitinen
Journal:  Isr J Med Sci       Date:  1976-07

Review 5.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

6.  Hormone profiles and psychological symptoms in peri-menopausal women.

Authors:  C B Ballinger; M C Browning; A H Smith
Journal:  Maturitas       Date:  1987-11       Impact factor: 4.342

7.  Yield of laboratory testing to identify secondary contributors to osteoporosis in otherwise healthy women.

Authors:  Cara Tannenbaum; Julie Clark; Kevin Schwartzman; Sylvan Wallenstein; Robert Lapinski; Diane Meier; Marjorie Luckey
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

8.  Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women.

Authors:  Hyun Tae Park; Geum Joon Cho; Ki Hoon Ahn; Jung Ho Shin; Soon Cheol Hong; Tak Kim; Jun Young Hur; Young Tae Kim; Kyu Wan Lee; Sun Haeng Kim
Journal:  Maturitas       Date:  2009-02-27       Impact factor: 4.342

9.  Recombinant human thyroid stimulating hormone does not acutely change serum osteoprotegerin and soluble receptor activator of nuclear factor-kappaBeta ligand in patients under evaluation for differentiated thyroid carcinoma.

Authors:  Massimo Giusti; Francesca Cecoli; Carla Ghiara; Alessandro Rubinacci; Isabella Villa; Domenico Cavallero; Laura Mazzuoli; Michele Mussap; Roberto Lanzi; Francesco Minuto
Journal:  Hormones (Athens)       Date:  2007 Oct-Dec       Impact factor: 2.885

10.  Major and minor discordance in the diagnosis of postmenopausal osteoporosis among Indian women using hip and spine dual-energy X-ray absorptiometry.

Authors:  Meeta Singh; Navneet Magon; Tanvir Singh
Journal:  J Midlife Health       Date:  2012-07
View more
  1 in total

Review 1.  Ionic regulation of cell volume changes and cell death after ischemic stroke.

Authors:  Mingke Song; Shan Ping Yu
Journal:  Transl Stroke Res       Date:  2013-12-07       Impact factor: 6.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.